Prof Leonid Churilov
Professor in Biostatistics
Department of Medicine
943 Scholarly works
41 Projects
HIGHLIGHTS
2026
Journal article
A tailored cognitive behavioural therapy intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): A randomised, assessor-blinded, active comparator trial
DOI: 10.1016/j.jad.2026.1219172026
Journal article
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
DOI: 10.1016/S0140-6736(26)00876-72026
Journal article
Minimal Sufficient Balance Randomization and Site-Specific Covariate and Group Size Imbalance in Multicenter Acute Stroke Trials.
DOI: 10.1161/STROKEAHA.126.0553152024
Research grants (ARC, NHMRC, MRFF)
Atrial Myopathy and Embolic Stroke (AMES) Trial
2022
Research grants (other domestic)
Australian Centre for Accelerating Diabetes Innovations (ACADI)
2021
Research grants (ARC, NHMRC, MRFF)
The Stroke Golden Hour
2017
Journal article
SCIPA Switch-On: A Randomized Controlled Trial Investigating the Efficacy and Safety of Functional Electrical Stimulation-Assisted Cycling and Passive Cycling Initiated Early after Traumatic Spinal Cord Injury
DOI: 10.1177/1545968317697035
RECENT SCHOLARLY WORKS
2026
Journal article
ABSTRACT NUMBER: ESOC2026LT15 LT15 - SAFETY AND EFFICACY OF RECOMBINANT HUMAN DNASE1 (DORNASE ALFA) AS AN ADJUVANT THROMBOLYTIC IN LARGE VESSEL ISCHAEMIC STROKE: THE EXTEND-IA DNASE CLINICAL TRIAL
DOI: 10.1093/esj/aakag023.18512026
Journal article
ABSTRACT NUMBER: ESOC2026A1553 NORMAL INTERHEMISPHERIC CEREBRAL BLOOD FLOW ASYMMETRY - IMPLICATIONS FOR DEFINING THE NO-REFLOW PHENOMENON
DOI: 10.1093/esj/aakag023.7412026
Journal article
ABSTRACT NUMBER: ESOC2026A1277 WHITE MATTER INJURY SEVERITY IS ASSOCIATED WITH WORSE FUNCTIONAL OUTCOME AFTER ISCHEMIC STROKE: A GRADED, TISSUE-SPECIFIC ADC AND KURTOSIS ANALYSIS
DOI: 10.1093/esj/aakag023.6202026
Journal article
ABSTRACT NUMBER: ESOC2026LT38 LT38 - AVERT DOSE: A PHASE III, MULTI-ARM, ADAPTIVE RANDOMISED TRIAL TO DETERMINE OPTIMAL EARLY (<48 HR START) MOBILITY TRAINING IN PATIENTS WITH MILD & MODERATE ISCHAEMIC STROKE
DOI: 10.1093/esj/aakag023.18562026
Journal article
ABSTRACT NUMBER: ESOC2026A865 RISK OF CARDIAC OUTCOMES FOLLOWING EMBOLIC STROKE OF UNDETERMINED SOURCE (ESUS) AND CRYPTOGENIC STROKE/TIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
DOI: 10.1093/esj/aakag023.4562026
Journal article
ABSTRACT NUMBER: ESOC2026A1002 PRIORITISING ACTIONS FOR THE GLOBAL YOUNG ADULT STROKE RESEARCH ALLIANCE TO MAXIMISE RESEARCH IMPACT
DOI: 10.1093/esj/aakag023.14692026
Journal article
ABSTRACT NUMBER: ESOC2026LT88 LT88 - RESULTS OF CENTRAL IMAGING ADJUDICATION FROM ANALYSIS OF MECHANICAL THROMBECTOMY FOR LARGE CORE ISCHEMIC STROKE (ATLAS) COLLABORATION – AN INDIVIDUAL-PATIENT-DATA META-ANALYSIS OF SIX RANDOMIZED CONTROLLED TRIALS
DOI: 10.1093/esj/aakag023.1878
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
“Managing Ourselves Better”: Co-Designing Diabetes Prevention, Care and Management Through Aboriginal and Torres Strait Islander Ways of Knowing, Being and Doing.